Average Co-Inventor Count = 6.06
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sugen Incorporated (17 from 157 patents)
2. Pharmacia & Upjohn Company (3 from 523 patents)
3. Other (2 from 832,718 patents)
4. Agouron Pharmaceuticals, Inc. (2 from 174 patents)
21 patents:
1. 7582756 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
2. 7572924 - Pyrrole substituted 2-indolinone protein kinase inhibitors
3. 7256189 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
4. 7214700 - (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors
5. 7186716 - 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
6. 7179910 - 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
7. 7125905 - Pyrrole substituted 2-indolinone protein kinase inhibitors
8. 7105562 - Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors
9. 7053086 - 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10. 7053114 - Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11. 6908930 - 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
12. 6861418 - 4-aryl substituted indolinones
13. 6797725 - Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
14. 6689806 - Indolinone compounds as kinase inhibitors
15. 6677368 - 4-aryl substituted indolinones